This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Evaluation
  • Claim Credit
Lysosomal Storage Disorders Common Presentations of Uncommon Diseases: Expert Guidance on Early Identification and Therapeutic Optimization

Lysosomal Storage Disorders Common Presentations of Uncommon Diseases: Expert Guidance on Early Identification and Therapeutic Optimization

Format

Patient Case Study

Time to Complete

1 hour

Released

August 30, 2019

Expires

August 30, 2020
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM

Accredited Provider


Jointly provided by the Postgraduate Institute for Medicine and Enquiring Minds, LLC.

Commercial Supporter

Supported by an independent educational grant from Sanofi Genzyme

Program Description

3 pediatric and adult patient cases that enable clinicians to evaluate and integrate expert guidance on differential diagnosis and therapeutic optimization.

Differential diagnosis

  • Clinical characteristics and phenotypes
  • Overlapping symptoms
  • Laboratory tests
  • Familial considerations

Therapeutic optimization

  • Benefit-risk profiles of available and investigational agents
  • Mechanisms of action, target patient populations
  • Evidence-based recommendations
  • Patient-centered considerations

Intended Audience

This activity is intended for neurology, pediatrics, primary care, genetic counselors, nurses, nurse practitioners, and other healthcare practitioners engaged in the care of patients with lysosomal storage disorders.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Differentiate key clinical characteristics of lysosomal storage diseases (LSDs) and consider how patient variability plays a role in their diagnosis and treatment
  • Discuss the implications of delayed diagnosis and treatment of LSDs
  • Evaluate and integrate current best practices and evolving therapeutic options for treating LSDs, taking into consideration patient and clinical factors that may influence therapeutic approach

Disclosure of Conflicts of Interest

The Postgraduate Institute for Medicine requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

Heather Lau, MD, MS
Director, Lysosomal Storage Disorders Program
Associate Director, Division of Neurogenetics
Department of Neurology
NYU School of Medicine
New York, NY

Dr. Lau receives advisory board fees from Amicus Therapeutics, Adult Polyglucosan Body Research Foundation, Avrobio, Biomarin, Chiesi, National Tay-Sachs & Allied Diseases Association, Sanofi Genzyme, Shire; Consulting fees from Actelion, Amicus Therapeutics, ASPA Therapeutics, BioMarin, Chiesi, Pfizer, Prevail Therapeutics, Sanofi Genzyme, Shire, Ultragenyx Pharmaceutical, Inc.; Contracted research fees from Amicus Therapeutics, BioMarin, Mallinckrodt, Pfizer, Protalix, Sangamo, Sanofi Genzyme, Shire, Ultragenyx Pharmaceuticals, Inc.

Kate Anstett, MS, CGC
Genetic Counselor
Department of Neurology
NYU Langone Health
New York, NY

Ms. Anstett receives consulting fees from Amicus Therapeutics

Accredited Provider Disclosure

Planners and Managers

The PIM planners and managers have nothing to disclose. The Enquiring Minds, LLC planners and managers have nothing to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement


In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Enquiring Minds, LLC. The Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM  .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Fee Information

There is no fee for this educational activity.

Media

Internet

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

There are no fees for participating and receiving CME/CE credit for this activity. During the period August 30, 2019 through August 30, 2020, participants must read the learning objectives and faculty disclosures and successfully complete the activity evaluation. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

System Requirements
Windows: Internet Explorer 11, Microsoft Edge (latest version), Google Chrome (latest version), Firefox (latest version)
Mac: Safari (latest version), Google Chrome (latest version), Firefox (latest version)
Mobile: Safari in Apple iOS 10 or later, Google Chrome in Apple iOS 10 or later, Google Chrome in Android 4.4 or later

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue